OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
30509060

Micro Digital Co Ltd

Medical Equipment, Supplies & DistributionVerified

Micro Digital Co Ltd has a liquidity position with a current ratio of 2.36, indicating the company can cover its short-term liabilities with its short-term assets. However, the company's operating cash flow is negative at -5,619,899,130 KRW, and its free cash flow is also negative at -18,678,765,220 KRW, suggesting challenges in generating positive cash from operations. The company's debt to equity ratio is 0.8, indicating a moderate level of leverage. In terms of profitability, the company is currently unprofitable, with a net income of -13,145,531,680 KRW and an operating income of -9,130,599,060 KRW. The return on equity is -0.454, and the return on assets is -0.2016, both indicating poor returns relative to equity and total assets. These metrics are below the industry norms for profitability and returns, as the company is not generating positive returns on its investments. The company's revenue is primarily derived from the bio healthcare sector, with a focus on healthcare bioprocesses, biomedicals, diagnostic kits, and consumables. The company operates in both domestic and overseas markets, but the input data does not provide specific details on the geographic distribution of its revenue. The company's growth trajectory is not clearly defined in the input data, as there are no numeric deltas provided for the current or next fiscal year. The company's capital expenditure is -7,877,868,540 KRW, indicating a reduction in capital spending. The company's operating cash flow and free cash flow are both negative, which may limit its ability to invest in growth opportunities. The company's risk assessment indicates a medium level of liquidity risk and a low level of dilution risk. The key flag of negative net cash after subtracting total debt suggests that the company may face liquidity challenges. The company's dilution potential is low, and there are no adjustments applied to the valuations. Recent events related to the company are not detailed in the input data, as there are no specific filings or transcripts provided. The company's financial performance and risk profile suggest that it may need to address its liquidity and profitability issues to sustain long-term growth.

30-day price · 305090-1835.00 (-32.2%)
Low$3780.00High$7020.00Close$3865.00As of21 May, 00:00 UTC
Profile
CompanyMicro Digital Co Ltd
Ticker305090.KQ
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryMedical Equipment, Supplies & Distribution
AI analysis

Business. Micro Digital Co Ltd provides total solutions in the bio healthcare sector, including healthcare bioprocesses, biomedicals, diagnostic kits, and consumables, primarily in domestic and overseas markets.

Classification. Micro Digital Co Ltd is classified in the Healthcare sector under the Medical Equipment, Supplies & Distribution industry with a confidence level of 0.92.

Micro Digital Co Ltd has a liquidity position with a current ratio of 2.36, indicating the company can cover its short-term liabilities with its short-term assets. However, the company's operating cash flow is negative at -5,619,899,130 KRW, and its free cash flow is also negative at -18,678,765,220 KRW, suggesting challenges in generating positive cash from operations. The company's debt to equity ratio is 0.8, indicating a moderate level of leverage. In terms of profitability, the company is currently unprofitable, with a net income of -13,145,531,680 KRW and an operating income of -9,130,599,060 KRW. The return on equity is -0.454, and the return on assets is -0.2016, both indicating poor returns relative to equity and total assets. These metrics are below the industry norms for profitability and returns, as the company is not generating positive returns on its investments. The company's revenue is primarily derived from the bio healthcare sector, with a focus on healthcare bioprocesses, biomedicals, diagnostic kits, and consumables. The company operates in both domestic and overseas markets, but the input data does not provide specific details on the geographic distribution of its revenue. The company's growth trajectory is not clearly defined in the input data, as there are no numeric deltas provided for the current or next fiscal year. The company's capital expenditure is -7,877,868,540 KRW, indicating a reduction in capital spending. The company's operating cash flow and free cash flow are both negative, which may limit its ability to invest in growth opportunities. The company's risk assessment indicates a medium level of liquidity risk and a low level of dilution risk. The key flag of negative net cash after subtracting total debt suggests that the company may face liquidity challenges. The company's dilution potential is low, and there are no adjustments applied to the valuations. Recent events related to the company are not detailed in the input data, as there are no specific filings or transcripts provided. The company's financial performance and risk profile suggest that it may need to address its liquidity and profitability issues to sustain long-term growth.
Key takeaways
  • Micro Digital Co Ltd is currently unprofitable with a net income of -13,145,531,680 KRW and an operating income of -9,130,599,060 KRW.
  • The company's liquidity position is moderate, with a current ratio of 2.36, but it has negative operating and free cash flows.
  • The company's return on equity is -0.454, and the return on assets is -0.2016, indicating poor returns relative to equity and total assets.
  • The company's debt to equity ratio is 0.8, indicating a moderate level of leverage.
  • The company's risk assessment indicates a medium level of liquidity risk and a low level of dilution risk.
  • # RATIONALES
  • margin_outlook_rationale: The company's margin outlook is negative due to its unprofitable operations and poor returns on equity and assets.
  • rd_outlook_rationale: The company's research and development outlook is not specified in the input data.
Financial snapshot
PeriodHA-latest
CurrencyKRW
Revenue$12.84B
Gross profit$3.64B
Operating income-$9.13B
Net income-$13.15B
R&D
SG&A
D&A
SBC
Operating cash flow-$5.62B
CapEx-$7.88B
Free cash flow-$18.68B
Total assets$65.20B
Total liabilities$36.25B
Total equity$28.95B
Cash & equivalents$16.27B
Long-term debt$23.28B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$28.95B
Net cash-$7.01B
Current ratio2.4
Debt/Equity0.8
ROA-20.2%
ROE-45.4%
Cash conversion43.0%
CapEx/Revenue-61.3%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Healthcare Services & Equipment · cohort 5 companies
Metric305090Activity
Op margin-71.1%13.3% medp25 5.9% · p75 13.5%bottom quartile
Net margin-102.4%8.6% medp25 2.7% · p75 12.7%bottom quartile
Gross margin28.3%64.0% medp25 60.1% · p75 65.6%bottom quartile
R&D / revenue6.9% medp25 6.7% · p75 7.1%
CapEx / revenue-61.3%3.0% medp25 2.7% · p75 4.5%bottom quartile
Debt / equity80.0%69.3% medp25 63.4% · p75 74.5%top quartile
Observations
IR observations
Mean price target28,000.00 KRW
Median price target28,000.00 KRW
High price target28,000.00 KRW
Low price target28,000.00 KRW
Mean recommendation1.00 (1=strong buy, 5=strong sell)
Strong-buy count1.00
Buy count0.00
Hold count0.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate372.00 KRW
Last actual EPS-737.00 KRW
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-10 07:05 UTC#4deaee52
Source: analysis-pipeline (hybrid)Generated: 2026-05-10 07:07 UTCJob: e7b64950